1,212
Views
0
CrossRef citations to date
0
Altmetric
Oncology

A prospective 5-year study of trismus prevalence and fluctuation in irradiated head and neck cancer patients

, ORCID Icon, , &
Pages 620-626 | Received 08 Feb 2022, Accepted 23 May 2022, Published online: 26 Jul 2022

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010;97(1):149–161.
  • Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg. 2006;35(4):337–342.
  • Kamstra JI, Dijkstra PU, van Leeuwen M, et al. Mouth opening in patients irradiated for head and neck cancer: a prospective repeated measures study. Oral Oncol. 2015;51(5):548–555.
  • Johnson J, Johansson M, Rydén A, et al. Impact of trismus on health-related quality of life and mental health. Head Neck. 2015;37(11):1672–1679.
  • Pauli N, Johnson J, Finizia C, et al. The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer. Acta Oncol. 2013;52(6):1137–1145.
  • Väst RC. Tillämpning av Nationellt vårdprogram för Huvud- och halscancer. 2019.
  • Pauli N, Fagerberg-Mohlin B, Andréll P, et al. Exercise intervention for the treatment of trismus in head and neck cancer. Acta Oncol. 2014;53(4):502–509.
  • Bhatia KS, King AD, Paunipagar BK, et al. MRI findings in patients with severe trismus following radiotherapy for nasopharyngeal carcinoma. Eur Radiol. 2009;19(11):2586–2593.
  • Watters AL, Cope S, Keller MN, et al. Prevalence of trismus in patients with head and neck cancer: a systematic review with Meta-analysis. Head Neck. 2019;41(9):3408–3421.
  • Kraaijenga SA, Oskam IM, van der Molen L, et al. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer. Oral Oncol. 2015;51(8):787–794.
  • Kraaijenga SA, van der Molen L, Jacobi I, et al. Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises. Eur Arch Otorhinolaryngol. 2015;272(11):3521–3531.
  • Karlsson O, Karlsson T, Pauli N, et al. Jaw exercise therapy for the treatment of trismus in head and neck cancer: a prospective three-year follow-up study. Support Care Cancer. 2021;29(7):3793–3800.
  • Ghazali N, Shaw RJ, Rogers SN, et al. Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review. Oral Oncol. 2012;48(11):1090–1100.
  • Lyons AJ, Crichton S, Pezier T. Trismus following radiotherapy to the head and neck is likely to have distinct genotype dependent cause. Oral Oncol. 2013;49(9):932–936.
  • van der Geer SJ, van Rijn PV, Kamstra JI, et al. Prevalence and prediction of trismus in patients with head and neck cancer: a cross-sectional study. Head Neck. 2019;41(1):64–71.
  • van der Geer SJ, van Rijn PV, Roodenburg JLN, et al. Prognostic factors associated with a restricted mouth opening (trismus) in patients with head and neck cancer: Systematic review. Head Neck. 2020;42(9):2696–2721.
  • Strojan P, Hutcheson KA, Eisbruch A, et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat Rev. 2017;59:79–92.
  • Lindblom U, Gärskog O, Kjellén E, et al. Radiation-induced trismus in the ARTSCAN head and neck trial. Acta Oncol. 2014;53(5):620–627.
  • Steiner F, Evans J, Marsh R, et al. Mouth opening and trismus in patients undergoing curative treatment for head and neck cancer. Int J Oral Maxillofac Surg. 2015;44(3):292–296.